Co‐expression profiling of CMTM6, EGFR, and/or RAB11 in the 92 cases indicated that the colocalization of CMTM6 with EGFR or RAB11 was detected in 29.75% and 29.88% of the tumor areas, respectively, and that the simultaneous colocalization of the three proteins was detected in 29.75% of the tumor areas (Figure 3C). The gene discussed is RAB11A; the disease is neoplasm.